
BMS-P5
CAS No. 1549811-36-0
BMS-P5( —— )
Catalog No. M27535 CAS No. 1549811-36-0
BMS-P5 is a specific and orally active Peptidylarginine Deiminase 4 (PAD4) inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 302 | Get Quote |
![]() ![]() |
10MG | 447 | Get Quote |
![]() ![]() |
25MG | 714 | Get Quote |
![]() ![]() |
50MG | 1017 | Get Quote |
![]() ![]() |
100MG | 1368 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBMS-P5
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS-P5 is a specific and orally active Peptidylarginine Deiminase 4 (PAD4) inhibitor.
-
DescriptionBMS-P5 is a specific and orally active Peptidylarginine Deiminase 4 (PAD4) inhibitor.
-
In VitroBMS-P5 blocks calcium ionophore-induced citrullination of histone H3.BMS-P5 is also able to inhibit formation of NETs induced by primary MM cells isolated from the BM of patients with MM. Cell Viability Assay Cell Line:Neutrophils.Concentration:10 μM and 100 μM.Incubation Time:30 min followed by addition of DP42 or 5TGM1 CM.Result:Prevented MM-induced NET formation.
-
In VivoBMS-P5 (50 mg/kg, oral gavage) significantly improves survival of MM-bearing mice.BMS-P5 (50 mg/kg, oral gavage) may attenuate the presence of pro-tumorigenic proteins in the tumor microenvironment, and thus delay tumor progression. Animal Model:Syngeneic mouse model of MM.Dosage:50 mg/kg.Administration:Oral gavage, twice a day beginning on day 3 after tumor cell injection.Result:Significantly delayed development of symptoms and significantly prolonged survival of MM-bearing mice.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorCOX|HO-1|NOS|Nrf2|PKC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1549811-36-0
-
Formula Weight509.04
-
Molecular FormulaC27H33ClN6O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=CC(OC)=C2C(N=C(N2C)C3=CC4=CC=CN=C4N3CC5CC5)=C1)N6[C@H](CC[C@H](C6)N)C.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nam JW, et al. Heat shock factor 1 inducers from the bark of Eucommia ulmoides as cytoprotective agents. Chem Biodivers. 2013 Jul;10(7):1322-7.
molnova catalog



related products
-
Mito-LND
Mito-LND is an orally active and mitochondria-targeted inhibitor of oxidative phosphorylation.
-
Corticotropin-releas...
Corticotropin-releasing factor human (Human CRF; Human corticotropin-releasing factor) is an immunomodulatory neuropeptide that acts to release ACTH from the anterior pituitary and stimulates the sympathetic nervous system and adrenal medulla. Functions by reducing hyperpolarizations. Acts as a functional antagonist of inflammatory mediators.
-
Dihydromyricetin
Dihydromyricetin is a potent inhibitor of dihydropyrimidinase with an IC50 of 48 μM. Dihydromyricetin can activate autophagy by inhibiting mTOR signaling.